Navigation Links
Pescatello Elected to Head New England Biotech Association in 2011-12
Date:1/18/2011

WAKEFIELD, Mass., Jan. 18, 2011 /PRNewswire/ -- Paul Pescatello has been re-elected as Chairman of the New England Biotech Association (NEBA) at the organization's annual meeting.

NEBA is a non-profit, member-driven organization comprised of state biotech associations, companies, academic institutions, and other organizations in the six New England states with a collective mission to support and grow the biotechnology industry in the region, and serves as the regional policy and public affairs voice for the biotechnology and biopharmaceutical industry.

Pescatello is President & CEO of CURE (Connecticut United for Research Excellence) the educational and business support network organization for bioscience in Connecticut, and will serve a two-year term as head of NEBA.  Pescatello served as NEBA Chairman in 2010 and has been a member of the board since the group's founding.  

"2011 brings with it many changes and challenges for the biotechnology and biopharmaceutical industry," said Pescatello.  "With new governors and legislatures in many New England states, it is critical that NEBA continues to educate our policy leaders about biotech and help create a positive regional environment for retention and growth."

"One of our priorities of the upcoming year will be to explore and explain the impact of national Health Care Reform Implementation and its impact on the biotech and biopharmaceutical industries in the six New England states," Pescatello continued.  "Clearly, NEBA can play a role in helping our members--as well as policy leaders and the public--better understand what it will mean for jobs and discovery in the biosciences field."

Representing over 600 members from all six New England states, NEBA is committed to educating policy makers and the public about the biotech industry; promoting public policies that foster innovation; encouraging economic development in the biotech sector; and advocating cont
'/>"/>

SOURCE New England Biotech Association
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Zila Inc. Product Selected to Identify Pre-Cancer in Study of Leading Cancer Treatment Chemotherapeutic - ERBITUX
2. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
3. GeoVax Labs, Inc. Selected by Georgia Bio as 2008 Deal of the Year Award Winner in Life Sciences Industry
4. Caliper Life Sciences Optical Imaging Technology Selected to Aid Tuberculosis Research Efforts by the Texas A&M Health Science Center
5. Cepheid GeneXpert(R) System and Xpert(TM) MRSA Selected for up to 11 Victoria, Australia Hospitals in Rollout of Start Clean Strategy
6. XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention
7. Texas Cardiac Arrhythmia Institute at St. Davids Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation
8. Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program
9. Jennerex Therapeutic Research Collaboration With Ottawa Hospital Research Institute Selected for $10 Million Grant From Ontario Institute for Cancer Research
10. Keryx Biopharmaceuticals Phase 2 Data of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Renal Cell Cancer Selected for Oral Presentation at the Eighth International Kidney Cancer Symposium
11. Sangamo BioSciences Announces Research Collaboration With UCLA in Human Stem Cells Selected to Receive Clinical Research Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... Research and Markets( http://www.researchandmarkets.com/research/ctd7zx/europe ) has announced the addition of ... (2014 - 2019)" report to their offering. ... Germany . This is followed by UK and ... Poland are the fastest growing segments. ... the basis of Product (Film Screen, Digital, 3D, Analog Systems, ...
(Date:6/2/2015)... Texas , June 2, 2015 ... report defines and segments the concerned market with ... valued at $261.8 million in 2014, and is ... a CAGR of 19.3% from 2014 to 2019. ... America Mannequin-Based Simulation Market for an analysis of ...
(Date:6/2/2015)... 2015 Intarcia Therapeutics, Inc. today ... its recently announced synthetic royalty / equity convert financing, ... have purchased Convertible Limited Recourse Notes from Intarcia and ... of any future global net sales of ITCA 650 ... also have the option, commencing upon U.S. regulatory approval ...
Breaking Medicine Technology:Europe Mammography Market Report 2014-2019 - Growth, Trends And Forecasts 2North America Mannequin-Based Simulation Market is Expected to Reach $632.5 Million by 2019, at a CAGR of 19.3% From 2014 to 2019 2North America Mannequin-Based Simulation Market is Expected to Reach $632.5 Million by 2019, at a CAGR of 19.3% From 2014 to 2019 3Intarcia Exercises Re-Opener For Its Recently Closed Royalty / Equity Convert Financing - Raising Total To $300 Million 2Intarcia Exercises Re-Opener For Its Recently Closed Royalty / Equity Convert Financing - Raising Total To $300 Million 3
...  Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that ... results on Thursday, April 26, 2012, before the U.S. financial ... 8:30 AM EDT that day. Live audio ... link to the webcast may be accessed from the ,Events ...
... Sunpeaks Ventures, Inc. (OTCBB: SNPK) (PINKSHEETS: SNPK) ... subsidiary Healthcare Distribution Specialists, LLC ("HDS") are pleased to ... DS Healthcare Limited to assist in introducing Clotamin to ... the agreement, DS Healthcare will evaluate the Clotamin formulation ...
Cached Medicine Technology:Sunpeaks Ventures Enters Agreement with UK Based Healthcare Firm to Introduce Clotamin to UK and European Union Countries 2
(Date:6/2/2015)... Erbelli’s Gourmet Pizzeria, Italian Bistro & ... handmade gourmet pizzas and calzones, fresh wraps, submarine sandwiches, ... new, the recipes are not—they have been satisfying the ... of the site is the menu, which is broken ... all the items. You can order directly from the ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 ZOOM+, the ... ZOOM+ Performance Health Insurance, announced today the opening of ... White 57 - a three-in-one complete dental exam, cleaning ... Jr. for kids. Like all ZOOM+ services, ZOOM+Smile can ... “Why shouldn’t the dentist office be as inviting as ...
(Date:6/2/2015)... June 02, 2015 Olive ... opening of Surrey’s first fertility clinic. Surrey ... a diverse, young community, with one of ... , Until now patients from Surrey ... to come into Vancouver or Burnaby for ...
(Date:6/2/2015)... TU-Automotive Detroit is the biggest dedicated B2B connected car ... execs from GM, Chrysler, Mercedes, Ford, TomTom, Zipcar, Nissan ... update on the automotive technology industry and a look ... secure one of the remaining passes. , Justin Parker, ... are 70 sessions looking across the connected car space ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 Vancouver, ... by iData Research ( http://www.idataresearch.com ), the bone ... demineralized bone matrices (DBM) over traditional allograft materials. ... incisions and thus an increase in operation time, ... strong market growth in these synthetic materials is ...
Breaking Medicine News(10 mins):Health News:Erbelli’s of Bradenton Launches New Mobile-Friendly Website 2Health News:ZOOM+ Opens Its First On-Demand ZOOM+Smile Studio and Reinvents the Dental Exam 2Health News:Olive Fertility Centre Opens First Fertility Clinic in Surrey BC 2Health News:The Connected Car’s Biggest Event is Here – TU-Automotive Detroit 2015 2Health News:Medtronic, DePuy Synthes Shift U.S. Bone Graft Substitute Market Towards Synthetic Demineralized Bone Matrices 2Health News:Medtronic, DePuy Synthes Shift U.S. Bone Graft Substitute Market Towards Synthetic Demineralized Bone Matrices 3
... 1 issue of the journal Sleep indicates that ... remain vigilant and attentive deteriorated significantly after losing less than ... study suggests that even moderate reductions in sleep duration can ... the academic performance of children with ADHD. Results of ...
... This release is also available in Chinese on ... Despite the absence of Medicare coverage, hospital use of computed ... the rise, according to a study in the March issue of ... www.jacr.org ). Colorectal cancer is the second leading cause of ...
... dissection, the current standard surgical treatment for localized non-small ... stage cases , according to a study published in the ... (JTO), the official journal of the International Association for the ... is very low in early-stage cancers with a maximum standard ...
... adhesive patches is at the center of an agreement ... arm of Italian pharmaceutical leader Zambon Co., SpA, to ... ways to deliver oral medications directly to a targeted ... sponsored research agreement between Zcube and UCSF, but is ...
... By Serena Gordon HealthDay Reporter , MONDAY, ... fears soaring as quickly as a child,s rapidly rising temperature. ... Pediatrics (AAP) attempts to allay those fears by reminding parents ... against illness, and that lowering a fever may actually prolong ...
... , MONDAY, Feb. 28 (HealthDay News) -- Many American women ... treatment was tied to higher breast cancer risk. A sharp ... after. However, a new study suggests that the 2002-2003 ... continue through 2007. The data suggests that the drop ...
Cached Medicine News:Health News:Moderate sleep loss impairs vigilance and sustained attention in children with ADHD 2Health News:Moderate sleep loss impairs vigilance and sustained attention in children with ADHD 3Health News:Hospital use of virtual colonoscopy is on the rise, study suggests 2Health News:Lymph node dissection is not essential in small screen-detected lung cancers, new research shows 2Health News:UCSF collaborates with Zcube to develop new ways to deliver drugs 2Health News:Kids' Fevers May Not Always Need Treatment 2Health News:Kids' Fevers May Not Always Need Treatment 3Health News:Drop in Breast Cancer Among White Women May Have Stalled 2
... Vessel Dissector has application for use in ... the extraperitoneal spaces such as the retroperitoneal, ... be used in surgical procedures requiring dissection ... harvesting of a quality conduit through a ...
... The Thoratec VAD System includes three ... Drive Console or TLC-II Portable Driver. This ... when the natural heart, with conventional therapy, ... perfuse vital organs. To accomplish support, blood ...
... two distinct polyethylene glycol polymers that combine to ... to chemically bond to each other, as well ... material forms a flexible, watertight seal that remains ... withstand arterial pressure. It is completely resorbed by ...
The Icy catheter is inserted into the femoral vein and resides in the inferior vena cava. Saline flow within the balloons creates a proprietary vortex flow pattern which maximizes heat exchange with...
Medicine Products: